Member Info for Porter_

Been saying for a while, the company no doubt have the skills for reversing gene damage such as via the covid vaccination. Good to see others finally recognising the company for its excellence.

Another one in the bag. Roll on the quarterly and year end report:

https://www.adsadvance.co.uk/dio-awards-mitie-256m-cyprus-facilities-management-contract.html

I was doing some studying and read the new patent application was published on the 19th January. My understanding is Eric already has a patent for a parent application, so would think this one is as good as approved. It’s just a waiting game for the official sign off from what I can see. Am I right that patents usually take 6 months to approve? If so, we should hear around the 19th June? Which really isn’t too far away at all?

BH brain :P
Let's hope for a better week to come, and have a fab few days rest :)

Agree. I get the feeling we will hear more news pretty soon. The patent approvals alone could land any day!

Q4 and year end results are just round the corner. Last year the SP jumped 24% on news. With all the new acquisitions now settled in and all the latest contract wins, I’m hoping for a rocket launch at this bargain price :)

Makes you wonder if the SP was taken down to fill that order as part of a negotiated buy…

Perhaps they’re waiting to release a bumper quarterly announcement and as you’ve noted, fireworks shall fill the skies :)

I know, it’s frustrating as 260 sites for total FM must be worth hundreds of £millions. It’s like the SP is being deliberately held down IMO. Makes me think even bigger news is in the pipeline. Someone is obviously loading as every night big UT’s go through in the hundreds of thousands and even millions.

On a roll with another amazing win, delivering total FM services for over 260 sites throughout the UK to National Grid!

https://www.fmj.co.uk/mitie-scoops-two-multi-million-pound-fm-deals-with-national-grid/

I’m really excited about their work, as if proven, surely they will be able to help reverse or control vaccine related genetic injuries?

“the company has expanded its intellectual property portfolio through a provisional patent application focusing on editing its SIRT6 gene, which plays a role in longevity and age-related diseases”

https://www.proactiveinvestors.co.uk/companies/news/1011164/genflow-biosciences-well-funded-and-making-headway-after-busy-q1-1011164.html

Mcap under £5m, human trials ready to begin, patent lodged and due any day for reverse and anti-aging gene, 2 year cash runway, in receipt of a series of government funds. Today’s RNS clearly shows the big boys are in town and ready to rumble.

Another contract renewal, this time a 3 year extension with Eurostar:

https://www.fmj.co.uk/mitie-renews-security-contract-with-eurostar/

Short version - Judas has received his bag of silver and hopped off into the sunset. Company has been pilferaged by the BOD to a tune of 139% share dilution. They’ve known about this scheme since last year and let shareholders continue investing, oblivious to their devious plan. Final chapter sees the introduction of new Kings to reign over the lands, yet reads hostile takeover to the mortal loyal peasants. The end.

Val confirmed in an interview, the company is in discussions to hold programme 2 in Australia. Would be amazing if so, as Australia seem keen to dispense clinically tested cannabinoids with THC.

Would be lovely to see the dot pop up at some point this week, with the MHRA approving in patient trials for chemotherapy and IBS related pain, whilst seeing the company gaining the recognition it deserves for all of its hard work!
Positive vibes!

400+ patents for cannabinoids and THC, mean the future looks bright for OCTP as soon as their MHRA approval lands:

https://www.globenewswire.com/news-release/2023/03/08/2623044/0/en/Medical-Marijuana-Market-Size-to-Hit-USD-248-42-Billion-by-2030-at-31-97-CAGR-Report-by-Market-Research-Future-MRFR.html

HL still showing as suspended so unable to buy

Yep, 427+ cannabinoid patents. Surely they must have one of the biggest , if not the biggest cannabinoid library. Must be worth a fortune to a big pharma or super rich investor looking for a jewel in their crown!

- MHRA approval
- US and Australian research partners confirmed
- Australian Medical Council and FDA applications submitted
- Government or research award non-dilutive grants
- Non-dilutive funding raised through the likes of Finncap
- Australian partner confirms that they will pay to develop programme 2 with no cost to the company or shareholders, with a view that they will offer a license payment system (similar systems tend to be £500m with milestone payments for sales, new offshot lines etc)
- Funding partners secured for programmes 3 and 4
- New programmes confirmed as ready to move through to trials
- New NED’s joining the board
- New 8.3’s, 8.5’s and TR1’s for new and increased holdings
- Applications to list on the Australian and US stock exchanges
- Buy out takeover offer received for 1 programme, the 4 programmes, the entire patent library, or the company as a whole